微信平台健康类公众号高血压推文准确性及其影响因素分析

Accuracy and influencing factors of hypertension-related subscriptions from official health WeChat accounts

目的分析微信平台上健康类公众号发布的“高血压防治与自我管理”相关中西医推文的阅读传播现状,评价其内容的准确性及影响因素。方法以“高血压”为关键词检索新榜《公众号月榜2022年9月中国微信500强·新榜认证》中健康板块36个微信公众号的推文,检索时限为2022年4月1日至2022年9月30日。与现行指南内容进行比较,将推文的准确性划分为与指南一致、不一致和未证实。采用SPSS 22.0软件进行统计分析。结果共纳入36个公众号发布的101篇高血压防治与自我管理相关推文,其中47篇(46.5%)推文内容与临床指南一致,7篇(6.9%)推文内容与指南不一致,47篇(46.5%)推文内容未证实,三者的阅读、在看和每千次点赞数差异具有统计学意义。有证据支持、有专家支持及由认证类型为“政府”的公众号发布的推文一致率更高。结论高血压主题推文存在很好的受众基础,但部分内容与现行临床指南推荐意见不一致,读者对此的甄别能力不强。微信平台高血压推文的撰写和发布需要构建和完善相关审核机制。

Objective To analyze the current state,evaluate the accuracy,and determine the influencing factors of hypertension-related subscriptions from official health WeChat accounts.Methods The 36 official health WeChat accounts on the WeChat official accounts monthly list│September 2022 China WeChat Top 500·New Rank certification were searched using the term"hypertension".We identified diabetes-related subscriptions published from April 1,2022 to September 30,2022.The accuracy of subscriptions was analyzed according to the consistency with clinical practice guidelines and was independently assessed by two specialists.SPSS 22.0 software was used for data analysis.Results One hundred and one subscriptions from 36 official health WeChat accounts were included.Forty-seven(46.5%)subscriptions were evaluated as consistent,seven(6.9%)subscriptions were evaluated as inconsistent,and forty-seven(46.5%)subscriptions were evaluated as unconfirmed.The differences between the numbers of reads,"wow"and"like"per thousand reads,were statistically significant.Consistency rates were higher for tweets backed by evidence and experts,and for tweets posted by public figures with the accreditation type"government".Conclusion Hypertension tweets have a good audience base,some of the content is inconsistent with current clinical guideline recommendations,and readers have little ability to screen them.There is a need to develop and improve the review mechanism for writing and publishing hypertension tweets on WeChat.